DNZOF(DNZOF)
DNZOF
No analyst ratings available
No analyst price targets available for DNZOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $7.70T | $7.92T | $8.17T | $8.53T | $8.79T |
| Low | $7.48T | $7.65T | $7.92T | $8.26T | $8.52T |
| High | $7.85T | $8.21T | $8.40T | $8.77T | $9.04T |
| EBITDA Avg | $935.32B | $962.07B | $992.56B | $1.04T | $1.07T |
| Low | $908.37B | $929.90B | $961.63B | $1.00T | $1.04T |
| High | $953.70B | $996.93B | $1.02T | $1.07T | $1.10T |
| EBIT Avg | $691.96B | $711.75B | $734.31B | $766.51B | $790.37B |
| Low | $672.03B | $687.95B | $711.43B | $742.62B | $765.74B |
| High | $705.56B | $737.54B | $754.91B | $788.01B | $812.54B |
| Net Income Avg | $457.26B | $512.18B | $572.93B | $627.38B | $715.19B |
| Low | $438.73B | $491.43B | $549.72B | $601.97B | $686.22B |
| High | $473.93B | $530.86B | $593.82B | $650.26B | $741.28B |
| EPS Avg | $167.92 | $188.09 | $210.40 | $230.40 | $262.65 |
| Low | $161.12 | $180.47 | $201.88 | $221.07 | $252.01 |
| High | $174.05 | $194.95 | $218.07 | $238.80 | $272.23 |
| Analysts (Rev / EPS) | 17 / 1 | 17 / 1 | 15 / 1 | 8 / 1 | 7 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.89T | $1.95T | $2.04T | $1.94T | $1.91T | $1.99T | $1.95T | $2.00T |
| Low | $1.78T | $1.84T | $1.92T | $1.83T | $1.80T | $1.87T | $1.84T | $1.89T |
| High | $1.94T | $2.01T | $2.09T | $1.99T | $1.96T | $2.04T | $2.00T | $2.05T |
| EBITDA Avg | $229.34B | $237.21B | $247.53B | $235.88B | $232.25B | $241.16B | $237.01B | $243.04B |
| Low | $216.23B | $223.66B | $233.38B | $222.40B | $218.98B | $227.38B | $223.46B | $229.15B |
| High | $235.51B | $243.59B | $254.18B | $242.22B | $238.50B | $247.64B | $243.38B | $249.58B |
| EBIT Avg | $169.67B | $175.49B | $183.12B | $174.51B | $171.82B | $178.41B | $175.34B | $179.81B |
| Low | $159.97B | $165.46B | $172.66B | $164.53B | $162.00B | $168.22B | $165.32B | $169.53B |
| High | $174.23B | $180.21B | $188.05B | $179.20B | $176.44B | $183.21B | $180.05B | $184.64B |
| Net Income Avg | $94.78B | $118.17B | $107.87B | $112.01B | $127.49B | $171.66B | $123.75B | $124.58B |
| Low | $87.74B | $109.39B | $99.86B | $103.69B | $118.02B | $158.91B | $114.56B | $115.32B |
| High | $98.10B | $122.30B | $111.65B | $115.93B | $131.95B | $177.66B | $128.08B | $128.93B |
| EPS Avg | $35.02 | $43.66 | $39.86 | $41.39 | $47.10 | $63.42 | $45.72 | $46.03 |
| Low | $32.42 | $40.42 | $36.90 | $38.31 | $43.61 | $58.71 | $42.33 | $42.61 |
| High | $36.24 | $45.19 | $41.25 | $42.83 | $48.75 | $65.64 | $47.32 | $47.64 |
| Analysts (Rev / EPS) | 4 / 1 | 3 / 1 | 3 / 1 | 2 / 1 | 2 / 1 | 3 / 1 | 2 / 1 | 1 / 1 |